I was thinking short squeeze when I saw the price, but volume is waaay too low, so the squeeze has not even started, but it may soon. Someone may be getting a call soon, ring ring, ah my shorty, we can no longer lend the shares, you will have to cover NOW.
Alexion is up a bit over $3 billion in market cap on the Roche rumor. This brings them north of a $20 billion market cap. Their lead drug brought in $1.3 billion in sales last year. I don't see Roche paying that much for a billion dollar drug. Their pipeline has some conjugated antibodies in it, but then why not just by IMGN who is one of the recognized leaders in that space. Might have to look at some ALXN puts because that take over does not make much sense to me.
Did you get those ALXN puts? They look fairly expensive, if you bought some in the money puts the other day, you might want to sell some lower priced puts today. I was a little early with the DIA and SPY puts. I bought them to hedge in an overbought market, but I still hate to see them decline even knowing I bought them for hedging risk.
I noticed an artice on CRIS this morning that makes an interesting case based on the early stage products. I am not a fan of CRIS management, but maybe they have some good new people that will move the company forward and stop making stupid financial decisions. I am ONLY going to buy this dog again on weakness, I will not pay high $3's.
I just noticed there's a rumor about Roche buying ALXN, so that's likely the reason for the rally. If they buy ALXN, they probably will not buy IMGN any time soon, so not sure why we are up on that other than more sector acquisitions are a +. ALXN seems wildly overvalued to me, they should buy IMGN instead. Shorts should be spooked.